Skip to main content
. 2021 Jul 12;9(7):e002444. doi: 10.1136/jitc-2021-002444

Figure 4.

Figure 4

(A) Impact of attenuating HER-2/CD3 BsAb affinity to CD3 (upper left panels), (B) HER-2 (upper right panels), or (C) both CD3 and HER-2 (bottom panels) on in vitro T cell redirected lysis activity towards OVCAR3 and SKOV3 tumor cells. On the upper panels, chSP34/Pertuz IgG BsAb and chSP34/Pertuz IgG BsAb2 are duplicates. BsAb, bispecific antibody; mAb, monoclonal antibody.